Rchr
J-GLOBAL ID:201401074851669410   Update date: Aug. 31, 2020

Ito Tatsuya

イトウ タツヤ | Ito Tatsuya
Affiliation and department:
Research field  (1): Medical equipment testing
Papers (18):
  • Lara Bernasconi, Selçuk Şen, Luca Angerame, Apolo P. Balyegisawa, Damien Hong Yew Hui, Maximilian Hotter, Chung Y. Hsu, Tatsuya Ito, Francisca Jörger, Wolfgang Krassnitzer, et al. Legal and ethical framework for global health information and biospecimen exchange - an international perspective. BMC Medical Ethics. 2020. 21. 1
  • Tatsuya Ito, Gillian Tallents, Liam McKervey, Rachel Davies, Anna Brooke, Jessica Bisset, Jake Harley, Birgit Whitman. A case study comparing research integrity, governance and ethics frameworks to facilitate collaboration between Bristol and Kyoto University. Clinical Ethics. 2017. 12. 4. 205-216
  • Tatsuya Ito. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries. PLOS ONE. 2016. 11. 2
  • Tatsuya Ito, Takashi Kaneta, Sue Sundstrom. Does university entrepreneurship work in Japan?: a comparison of industry-university research funding and technology transfer activities between the UK and Japan. Journal of Innovation and Entrepreneurship. 2016. 5. 8. 1-21
  • Tatsuya Ito. Clinical development of Metreleptin for lipodystrophy. Clinical Evaluation. 2014. 42. 1. 107-117
more...
MISC (16):
  • 伊藤 達也, 池田浩治, 菅原岳史, 伊師賢樹, 山地学, 植田康平, 岡田潔, 名井陽. 橋渡し支援拠点間連携としてのARO薬事専門家連絡会の活動. 第1回RSのあり方研究会. 2017
  • 伊藤 達也. アカデミアにおける臨床開発支援 ~希少疾病薬レプチンの開発~. 第31回日本薬剤学会学術大会. 2016
  • Tatsuya Ito. Differences of characteristics in investigator-initiated trials between Japan and other countries. 28th DIA Annual EuroMeeting. 2016
  • Tatsuya Ito, Gillian Tallents, Liam McKervey, Rachel Davies, Jessica Bisset, Jake Harley, Diana Benton, Birgit Whitman. Comparison of the research governance frameworks for research involving humans, their tissue and/or data in the UK and Japan. 27th DIA Annual EuroMeeting. 2015
  • N. Morimoto, K. Yoshimura, M. Niimi, T. Ito, R. Aya, J. Fujitaka, H. Tada, S. Teramukai, T. Murayama, C. Toyooka, et al. Erratum: Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: Clinical trial for chronic skin ulcers (Tissue Engineering, Part A (2013) 19:17 (1931-1940)). Tissue Engineering - Part A. 2014. 20. 2030
more...
Lectures and oral presentations  (5):
  • アカデミアにおける臨床開発の実践 ~希少疾病薬レプチンの開発~
    (長崎大学医歯薬学総合研究科アカデミア創薬ユニット 第1回アカデミア創薬シンポジウム 2016)
  • 臨床中核病院事業における取り組み
    (第15回CRC養成フォローアップ研修会プログラム 2013)
  • 京都大学病院における希少疾病薬開発
    (第4回日本臨床試験研究会学術集会 2013)
  • 再生医療を早期に臨床応用へと繋ぐための橋渡し研究
    (第2回DDS徐放化再生医療研究会 2012)
  • 高度医療評価制度下で実施する臨床試験の支援 -希少難治性疾患領域の臨床試験を支援する-
    (研究者主導臨床試験の支援シリーズセミナー 2011)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page